| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.063 | 0.3 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |